The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
Crossref DOI link: https://doi.org/10.1186/s12885-015-1302-1
Published Online: 2015-04-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ho, Thai H
Liu, Xian-De
Huang, Yanqing
Warneke, Carla L
Johnson, Marcella M
Hoang, Anh
Tamboli, Pheroze
Wang, Fen
Jonasch, Eric
License valid from 2015-04-18
Article History
Received: 3 November 2014
Accepted: 31 March 2015
First Online: 18 April 2015